Delhi Police have arrested two men — a 35-year-old property owner and a 19-year-old omelette vendor — for allegedly snatching ...

WASHINGTON, DC – U.S. journalist Raphael Satter has filed a lawsuit against the Indian government after his Overseas Citizen of India (OCI) status was revoked following a critical article about ...

WASHINGTON, April 2 (Reuters) - The U.S. Supreme Court on Wednesday largely backed the U.S. Food and Drug Administration's refusal to let two e-cigarette companies sell flavored vape products that ...

New OCI Compute E6 shapes boost performance for demanding workloads with AMD's latest server CPUs. Feel unsure about the market’s next move? Copy trade alerts from Matt Maley—a Wall Street ...

WASHINGTON — The top vaccine official with the Food and Drug Administration has resigned and criticized Health Secretary Robert F. Kennedy Jr. for allowing “misinformation and lies” to guide ...

A top vaccine official at the Food and Drug Administration (FDA) resigned, citing Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s “misinformation” and apparent lack of ...

The Delhi High Court on Friday set aside a 2023 order of the Centre cancelling the OCI card of Sweden-based professor Ashok Swain. This is the second time that the HC is setting aside an order of ...

The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH workers as part of an overarching move designed to eliminate 10,000 jobs in the Department of Health and Human ...

On Thursday, the government said it will cut jobs across health agencies, including 3,500 at the U.S. Food and Drug Administration, a follow-on to earlier layoffs. Sign up here. Two of the ...

Artificial intelligence (AI) has taken the biotech industry by storm, allowing companies to speed up the drug discovery process while also making it more cost-effective. With so many companies in the ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections (UTIs), the first such drug approved in decades and the first in a new class of medications.

The Senate Tuesday confirmed Dr. Marty Makary to run the Food and Drug Administration and Dr. Jay Bhattacharya to lead the National Institutes of Health. Both were confirmed largely along party lines.